The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants
about
sameAs
How to calculate the dose of chemotherapyEvolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors).Role of pregnane X receptor in chemotherapeutic treatmentPregnane X Receptor (PXR)-Mediated Gene Repression and Cross-Talk of PXR with Other Nuclear Receptors via Coactivator InteractionsPXR variants: the impact on drug metabolism and therapeutic responsesPharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationFunctionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping testsHuman pregnane X receptor: genetic polymorphisms, alternative mRNA splice variants, and cytochrome P450 3A metabolic activityInduction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formulaEvolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile saltsHuman pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alphaPolymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes.Explaining variability in ciclosporin exposure in adult kidney transplant recipients.Photochemotherapeutic agent 8-methoxypsoralen induces cytochrome P450 3A4 and carboxylesterase HCE2: evidence on an involvement of the pregnane X receptor.Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinomaPXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisininActivation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.Genetic variation in aldo-keto reductase 1D1 (AKR1D1) affects the expression and activity of multiple cytochrome P450s.Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel diseaseFunctional interactions between P-glycoprotein and CYP3A in drug metabolism.The pharmacogenomics of HIV therapy.The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium FerulateInduction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2Pharmacogenetics of the major polymorphic metabolizing enzymes.Frequency of genetic polymorphisms of PXR gene in the Brazilian population.The role of clinical pharmacology in optimizing antiretroviral therapy.Drug-activated nuclear receptors CAR and PXR.Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.Suppression of the pregnane X receptor during endoplasmic reticulum stress is achieved by down-regulating hepatocyte nuclear factor-4α and up-regulating liver-enriched inhibitory protein.CYP3A5 phenotype-genotype correlations in a British population.Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis TreatmentEffect of Pregnane X Receptor*1B genetic polymorphisms on postoperative analgesia with fentanyl in Chinese patients undergoing gynecological surgery.Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.Overview of the pharmacogenetics of HIV therapy.Functional evolution of the pregnane X receptor.Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.
P2860
Q24642872-9B6A41CE-0A9C-43C1-AFB3-2FAFFA51009FQ24815571-FF1C7B31-B9D0-46A0-A8D3-4C1C0F269FCFQ26827398-8607643C-3238-45A6-981F-F7446C50970AQ28072512-C46003E2-8F87-461E-867E-720F39B3DAFEQ28080023-80A54BD7-658D-477D-931C-33925CC15C84Q28083875-499E930D-5208-4079-B8A9-F953233A4B66Q28260518-C977AB93-9F8E-401F-9FE1-949B2A1BBB13Q28269219-5A4224AB-9944-44F7-925E-468CCCDCE69CQ28391251-63052858-A978-4118-AC0D-EEF03F1E06FDQ28755660-06AD8ACC-BE7B-4B56-AFA0-DAB37F1D86C9Q33345012-C469F6AA-D8F1-4529-AEBB-E6A70A211BBAQ33690892-C73E2189-017C-43B4-95EA-FF13FA957665Q33847140-9329A420-A3C5-4501-B32F-3998ED29BCF0Q33967328-923BAC04-B145-4E1A-A68D-38F99681BCF6Q34041770-7FB430AB-3ED7-41F6-B8A0-8AA99876F88BQ34129977-162151A3-7DFF-47EE-835C-A36400FBBE7AQ34149359-C7393F24-41FF-41EE-9AF6-3C21152BC120Q34169795-EC1CF579-8D41-4268-967E-032439DEAF5BQ34487187-52796FF2-29F0-4740-901F-F22075753FA2Q34550483-C750E4EE-9AF8-46E6-B6A7-ECB4CBDBC096Q34574033-5A85679C-242F-4895-9FB3-013A2BFC2B72Q34612112-EF31CB8E-9C2A-4BA2-B22B-310163612352Q34804191-7295D4BF-6193-4AF2-B4FE-CED14F6A67EFQ35001199-B2DD0E65-E027-4758-B841-972FEBD6C272Q35067187-180EC526-48A2-4833-B4FB-F875D9E35DA0Q35087215-7EA81232-4EA9-4948-8612-12CBB890492EQ35130818-6F660D24-A463-442F-8DCE-944878890D94Q35160978-74A2D085-4E16-4E04-8ADE-A33F78B985ABQ35164664-B201638B-CF70-4C1F-8A1E-41AE534CEFB1Q35210306-DF6243A7-0CE4-4202-83AF-5D870188A8EEQ35214618-112B3E3F-DB6E-4B64-8F34-5C205273AEBEQ35825323-E068673D-1E51-4CAC-86BD-397BE7FA58CCQ36194503-32DCCB04-1B9A-45E2-B225-03A5BA33A5A0Q36201399-0C0939D5-29F5-4D9E-BEB6-9B8A48C8E756Q36285918-1FB967B7-DA19-4F9C-B43C-3BE24D1C3434Q36375432-0BB63D95-638C-4F34-B166-158AB1E0F0F9Q36389312-AE5EC857-0762-4614-9102-D826E5832C95Q36440155-FF4B1709-679E-47BD-A217-00B20C6EA7EEQ36440873-FB0943FA-5EC2-49E2-BDFD-0FC161E90290Q36468872-3C2455A1-E280-4E57-BA42-B72D4BA22137
P2860
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The human pregnane X receptor: ...... on of natural allelic variants
@ast
The human pregnane X receptor: ...... on of natural allelic variants
@en
The human pregnane X receptor: ...... on of natural allelic variants
@nl
type
label
The human pregnane X receptor: ...... on of natural allelic variants
@ast
The human pregnane X receptor: ...... on of natural allelic variants
@en
The human pregnane X receptor: ...... on of natural allelic variants
@nl
prefLabel
The human pregnane X receptor: ...... on of natural allelic variants
@ast
The human pregnane X receptor: ...... on of natural allelic variants
@en
The human pregnane X receptor: ...... on of natural allelic variants
@nl
P2093
P3181
P1476
The human pregnane X receptor: ...... on of natural allelic variants
@en
P2093
C G Russell
E G Schuetz
J R Hudson
J W Touchman
P304
P3181
P356
10.1097/00008571-200110000-00003
P407
P577
2001-10-01T00:00:00Z